Key facts
- It has raised $65.1M; the latest was Later Stage VC ($40.0M) in Nov 2024.
- Notable investors include Samsung NEXT Ventures, Citigroup Alternative Investments, BrightEdge, OSF Ventures, University Hospitals Ventures — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for TailorMed
- ·The full record, as it builds
Funding rounds
No funding rounds for TailorMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TailorMed
Developer of a medical financial management platform designed for chronically ill patients to streamline their finances. The company's platform identifies patients with financial risk, matches them to personalized funding opportunities, and manages enrollment into appropriate programs, enabling healthcare providers to analyze insurance benefits, project out-of-pocket costs, and enhance cost optimization to facilitate high-cost medical attention.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 192
- Website
- tailormed.co/
- Ownership
- Privately Held (backing)
TailorMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TailorMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TailorMed in its N-PORT filings yet. We sweep new filings monthly.